Search
News
Inspire Q2 2026 Earnings: Revenue Falls as Gross Margin Expands
Inspire Medical Systems’ Q2 2026 revenue fell 7.6% to $200.6 million as U.S. coding and reimbursement changes weighed on sales. Diluted EPS improved to $0.01 from a $0.12 loss, while gross margin expanded 150 basis points to 85.5% on a richer Inspire V mix. Operating cash flow increased to $23.2 million, supported by working-capital improvements. The company raised full-year revenue guidance to $835 million-$875 million and announced Project Horizon, which targets about $30 million of annualized growth investment capacity while carrying $20 million-$25 million of expected pre-tax restructuring charges.
TradingKey
Mon, Aug 3
Vertex Q2 2026 earnings: Cloud growth lifts adjusted EBITDA margin to 25%
Vertex, Inc. (VERX) reported Q2 2026 revenue of $204.0 million, up 10.5% year over year, and GAAP diluted EPS of $0.06 versus a $0.01 loss a year earlier. Cloud revenue rose 17.9%, while adjusted EBITDA increased to $51.0 million and margin expanded to 25.0%. However, the GAAP operating loss widened slightly to $4.4 million and quarterly free cash flow fell to $2.7 million. Vertex narrowed full-year revenue guidance to $825-$830 million and raised adjusted EBITDA guidance to $206-$210 million.
TradingKey
Mon, Aug 3
EverQuote Q2 2026 Earnings: Revenue Rises 25% as Adjusted EBITDA Hits a Record
EverQuote’s Q2 2026 revenue increased 24.6% year over year to $195.1 million, while diluted EPS rose to $0.53 from $0.39. GAAP operating income grew 65.8% to $23.5 million, and non-GAAP adjusted EBITDA reached a record $30.1 million, up 37.1%. Automotive and home and renters revenue both expanded, though quarterly operating cash flow edged down to $24.3 million. For Q3, EverQuote expects revenue of $198 million to $208 million and adjusted EBITDA of $28 million to $31 million, with management citing healthy carrier demand across digital channels.
TradingKey
Mon, Aug 3
Ethos Q2 FY2026 Earnings: Revenue More Than Doubles as Contribution Margin Narrows
Ethos reported Q2 FY2026 revenue of $189.6 million, up 113% year over year, while diluted GAAP EPS slipped to $0.30 from $0.31 and net income rose to $19.5 million. Direct-channel revenue climbed 131%, supported by 133% growth in new policy activations, although average revenue per unit fell 8% on channel and product mix. Adjusted EBITDA reached $35.2 million, but its margin narrowed to 19%. Q3 guidance calls for $160 million to $164 million in revenue, below the Q2 level on a sequential basis.
TradingKey
Mon, Aug 3
SI-BONE Q2 2026 Earnings: Revenue Rises 15.2% as Loss Narrows
SI-BONE (SIBN) reported Q2 2026 revenue of $56.0 million, up 15.2% year over year, while diluted loss per share improved to $0.09 from $0.14. Net loss narrowed 33.6% to $4.1 million, and adjusted EBITDA increased to $2.8 million from $1.0 million as revenue grew faster than operating expenses. U.S. procedure volume rose 14.9%, supporting 14.7% U.S. revenue growth. The company raised the low end of 2026 revenue guidance to $231 million and reduced expected operating-expense growth to about 12%.
TradingKey
Mon, Aug 3
Powell Q3 FY2026 earnings: Record orders lift backlog to $2.4 billion
Powell Industries’ fiscal third-quarter 2026 revenue rose 9% year over year to $311.7 million, while diluted EPS increased to $1.42 from $1.32. Gross margin held nearly flat at 30.6%, supporting net income of $52.2 million. The more consequential change was in demand: new orders surged 158% to a record $934 million, lifting backlog 69% to $2.4 billion. Commercial and Other Industrial revenue grew 54% and Electric Utility revenue increased 18%, partly offset by a 49% decline in Petrochemical revenue. Management is adding capacity as it works to convert the larger backlog.
TradingKey
Mon, Aug 3
Hess Midstream Q2 2026 earnings: Lower throughput cuts revenue as free cash flow rises
Hess Midstream LP’s Q2 2026 revenue fell 3.7% year over year to $399.0 million as lower new-well activity and planned maintenance reduced throughput. Diluted EPS increased to $0.75 from $0.74, while consolidated net income declined to $173.7 million. Adjusted Free Cash Flow rose 19.5% to $231.6 million, largely reflecting a 56% reduction in capital spending after completion of a gas-compression expansion. The company reaffirmed its full-year 2026 financial and throughput guidance, although first-half averages remained below the guided throughput ranges.
TradingKey
Mon, Aug 3
EchoStar Q2 2026 earnings: A non-cash gain drives the profit swing
EchoStar’s Q2 2026 earnings showed revenue of $3.58 billion, down about 4.0% year over year, while diluted EPS swung to $24.12 from a $1.06 loss. Reported net income attributable to EchoStar reached $8.46 billion, but the result was driven primarily by a $9.73 billion non-cash deconsolidation gain; excluding its tax-affected impact, net income would have been about $49.46 million. Adjusted OIBDA rose to $681.2 million from $279.6 million even as pay-TV, wireless and broadband subscribers declined, and operating income turned positive.
TradingKey
Mon, Aug 3
Costamare Bulkers Q2 2026 Earnings: Derivative Marks Widen the Adjusted Profit Gap
Costamare Bulkers’ Q2 2026 earnings included $111.6 million of total voyage revenue, $5.2 million of GAAP net income, or $0.21 per share, and $9.8 million of adjusted net income, or $0.40 per share. The gap largely reflected a $3.7 million adjustment for derivative losses excluding realized effects. Operating cash flow was $1.3 million, while quarter-end liquidity reached $331.5 million and cash plus margin deposits exceeded debt by $108.9 million. The company also completed the Cargill trading-book transfer and agreed to sell the 2009-built Bermondi.
TradingKey
Mon, Aug 3
Kosmos Energy Q2 2026 earnings: Production growth and higher prices lift revenue
Kosmos Energy’s Q2 2026 oil and gas revenue rose 54.7% to $607.3 million, while diluted EPS improved to $0.31 from a $0.18 loss. Net production increased about 12% to 71,400 boepd as GTA ramped and new Jubilee wells came online, while production expense fell 26% to $179.4 million. Free cash flow nearly doubled to $88.9 million, and net debt declined to $2.56 billion. Updated 2026 guidance reflects the Equatorial Guinea asset sale, while hedge cash settlements reduced realized revenue despite higher reported sales.TradingKey
Mon, Aug 3
Oxford Square Q2 2026 Earnings: Realized Losses and Distributions Pressure NAV
Oxford Square Capital Corp. (OXSQ) reported Q2 2026 total investment income of $9.4 million, compared with $9.5 million a year earlier, while net investment income declined to $5.1 million, or $0.05 per share, from $5.5 million, or $0.08. NAV ended June 30 at $1.29 per share, down from $1.32 at March 31, as realized losses and distributions pressured book value. The company issued 11.3 million shares for $17.8 million of net proceeds and maintained monthly distributions of $0.035 per share for October through December.TradingKey
Fri, Jul 31
RBC Bearings Fiscal Q1 2027 Earnings: Aerospace Growth Lifts Margins
RBC Bearings’ fiscal Q1 2027 net sales rose 19.2% to $519.5 million, while diluted EPS increased to $3.20 from $2.17. Gross margin expanded to 47.7% from 44.8%, led by Aerospace & Defense sales growth of 36.9%, while acquired VACCO contributed $34.4 million of revenue. Operating cash flow reached $171.8 million. For fiscal Q2, management expects $505 million to $515 million in sales and a 45.5% to 45.75% gross margin, implying continued growth but a sequential margin decline.
TradingKey
Fri, Jul 31
InTest Q2 2026 preliminary earnings: Revenue guidance rises as margin target falls
InTest’s preliminary Q2 2026 results put revenue at approximately $35 million, above its prior $32 million to $34 million range, while gross margin was about 40% and operating expenses were estimated at $13.9 million. Unfavorable Alfamation project mix and a supply-chain delay affecting roughly $2 million of ITS revenue drove the margin shortfall. InTest raised full-year revenue guidance to $135 million-$140 million but lowered its gross-margin outlook to about 43%. It also plans a $750,000 downward revision to first-quarter gross profit tied to Alfamation ERP and inventory issues.
TradingKey
Fri, Jul 31
IES Fiscal Q3 2026 Earnings: Data Center Demand Drives 40% Revenue Growth
IES Holdings’ fiscal Q3 2026 revenue rose 40% to $1.243 billion, while diluted EPS increased to $7.57 from $3.81 and operating income advanced 60% to $178.5 million. Data center demand lifted Communications, Infrastructure Solutions, and Commercial & Industrial, more than offsetting a 6% Residential revenue decline. Backlog reached $4.53 billion, supported by expanded capacity and larger projects, while the company ended June 30 with $77.3 million in cash, $310.6 million in marketable securities, and no debt. Infrastructure acquisition investments and housing weakness remain important areas to monitor.
TradingKey
Fri, Jul 31
AbbVie Q2 2026 earnings: Immunology and neuroscience drive 10.2% revenue growth
AbbVie (NYSE: ABBV) reported Q2 2026 net revenue of $16.990 billion, up 10.2% year over year, with GAAP diluted EPS rising to $2.03 from $0.52 and adjusted diluted EPS increasing 22.9% to $3.65. Immunology revenue grew 15.1% as Skyrizi and Rinvoq more than offset Humira’s decline, while neuroscience advanced 20.3%. GAAP profitability also benefited from lower acquired IPR&D, contingent consideration expense, and tax costs. AbbVie lowered full-year adjusted EPS guidance to $13.87-$14.07 to include dilution from its proposed $10.9 billion Apogee Therapeutics acquisition.
TradingKey
Fri, Jul 31
Dominion Energy Q2 2026 earnings: Operating EPS rises as GAAP profit falls
Dominion Energy reported second-quarter 2026 operating revenue of $4.48 billion, up about 18% year over year, while GAAP diluted EPS fell to $0.37 from $0.88. Non-GAAP operating earnings increased to $712 million, or $0.79 per share, as Dominion Energy Virginia offset weaker contributions from South Carolina, Contracted Energy, and Corporate and Other. The sharp GAAP decline reflected impairment-related and regulated asset retirement charges, partly offset by nuclear decommissioning trust gains. The company reaffirmed full-year operating EPS guidance of $3.45 to $3.69.
TradingKey
Fri, Jul 31
Cboe Q2 2026 earnings: Options growth lifts net revenue 25%
Cboe Global Markets’ Q2 2026 earnings featured record net revenue of $731.6 million, up 25% year over year, and diluted EPS of $3.35, up 50%. GAAP operating margin expanded 7.4 percentage points to 65.1% as operating expenses rose only 3%, while Options net revenue climbed 30% to $473.9 million. Cboe raised its 2026 organic net revenue growth target to the mid-to-high teens and Data Vantage’s target to the low teens, kept adjusted operating expense guidance at $838 million to $853 million, and increased its capital expenditure range.
TradingKey
Fri, Jul 31
Gates Industrial Q2 2026 earnings: Higher sales support raised guidance
Gates Industrial’s Q2 2026 net sales rose 6.6% to $941.6 million, while core sales increased 4.9%. Diluted EPS climbed to $0.67 from $0.22, helped by a $78.0 million income tax benefit; adjusted EPS was $0.44. Adjusted EBITDA rose 6.1% to $211.4 million, with margin unchanged at 22.5%. Power Transmission outpaced Fluid Power on profit growth, and the company raised its full-year core sales, adjusted EBITDA and adjusted EPS guidance while leaving capital spending and free cash flow conversion targets unchanged.
TradingKey
Fri, Jul 31
Moderna Q2 2026 Earnings: Lower Costs Narrow the Net Loss
Moderna’s Q2 2026 revenue edged up to $145 million from $142 million, while GAAP loss per share narrowed to $1.97 from $2.13. Cash, cash equivalents and investments ended June at $6.9 billion. Lower R&D and SG&A spending helped reduce the quarterly net loss by 5%, and the company lowered its 2026 cost outlook while raising expected year-end liquidity. Pipeline developments were mixed: mFLUSIVA had an August 5 PDUFA date, but the Phase 3 norovirus program did not meet the interim threshold for early success.
TradingKey
Fri, Jul 31
GCL FY2026 Earnings: Revenue Growth Came With Lower Margins and a Net Loss
GCL Global Holdings’ FY2026 revenue rose 68.2% to US$238.9 million, but gross margin fell to 10.3% from 15.0% as lower-margin distribution represented more of the expanded sales base. The company recorded a US$26.2 million net loss and a diluted loss of US$0.20 per share, reversing the prior year’s profit. Cash increased to US$36.6 million, while inventory reached US$32.4 million and bank borrowings totaled about US$54.0 million. Management is prioritizing higher-margin publishing, operating efficiencies, cash conversion and lower leverage.TradingKey
Fri, Jul 31
Featured Tools
Top News
Amazon Stock Forecast: AMZN Needs a Close Above $258 as Q3 Tests Its AI Spending
Amazon Shares Plunge 11% After Hours as Q3 Revenue Misses Estimates, Free Cash Flow Negative $33.456 Billion
Marvell’s Proposed Acquisition of Lumentum Sparks Pre-Market Divergence in Optical Communications Stocks: MRVL Falls Over 11%, LITE Rises Over 4%, COHR Slips 0.63%
The Future of AI 3D Character Workflows: Reallusion CC 5.2 Turns Meshes into Living Characters
Amazon Q3 Earnings Preview: AWS Growth Expected to Rise to 41%, Wall Street Top Price Target $400